SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CUNEO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.053
AS - Asia 20.611
EU - Europa 11.019
SA - Sud America 3.326
AF - Africa 420
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 16
AN - Antartide 1
Totale 70.499
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.267
SG - Singapore 7.580
CN - Cina 4.905
BR - Brasile 2.623
VN - Vietnam 2.363
DE - Germania 2.091
IT - Italia 1.982
HK - Hong Kong 1.769
UA - Ucraina 1.767
TR - Turchia 1.289
GB - Regno Unito 1.020
FI - Finlandia 984
FR - Francia 778
BD - Bangladesh 666
RU - Federazione Russa 607
JP - Giappone 554
PL - Polonia 519
SE - Svezia 468
IN - India 387
CA - Canada 339
MX - Messico 339
ID - Indonesia 302
AR - Argentina 253
ZA - Sudafrica 175
NL - Olanda 158
IQ - Iraq 141
EC - Ecuador 115
ES - Italia 103
PK - Pakistan 103
CZ - Repubblica Ceca 96
BE - Belgio 94
CO - Colombia 79
UZ - Uzbekistan 78
AT - Austria 75
VE - Venezuela 74
CL - Cile 73
LT - Lituania 62
MA - Marocco 59
SA - Arabia Saudita 54
AE - Emirati Arabi Uniti 53
MY - Malesia 51
PH - Filippine 48
AU - Australia 46
TN - Tunisia 38
PY - Paraguay 35
KE - Kenya 32
JO - Giordania 30
PE - Perù 30
IL - Israele 29
EG - Egitto 27
IE - Irlanda 26
CH - Svizzera 25
RO - Romania 25
BO - Bolivia 22
NP - Nepal 22
AZ - Azerbaigian 21
DZ - Algeria 21
OM - Oman 21
DO - Repubblica Dominicana 19
TH - Thailandia 19
ET - Etiopia 18
UY - Uruguay 18
AL - Albania 16
JM - Giamaica 16
RS - Serbia 16
KR - Corea 15
KZ - Kazakistan 15
LV - Lettonia 14
IR - Iran 13
HU - Ungheria 12
PS - Palestinian Territory 12
TT - Trinidad e Tobago 12
EU - Europa 10
LB - Libano 10
CR - Costa Rica 9
HN - Honduras 9
HR - Croazia 9
PA - Panama 9
YE - Yemen 9
BG - Bulgaria 8
DK - Danimarca 8
SI - Slovenia 8
TW - Taiwan 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
KG - Kirghizistan 7
NI - Nicaragua 7
PT - Portogallo 7
BB - Barbados 6
BH - Bahrain 6
MD - Moldavia 6
NG - Nigeria 6
PR - Porto Rico 6
GE - Georgia 5
LY - Libia 5
QA - Qatar 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
GR - Grecia 4
ME - Montenegro 4
Totale 70.401
Salva come PNG Salva come JPEG
Città #
Singapore 4.819
Ashburn 3.944
Fairfield 3.017
Woodbridge 2.968
Houston 2.052
San Jose 2.042
Jacksonville 1.865
Hong Kong 1.742
Chandler 1.678
Beijing 1.549
Santa Clara 1.420
Ann Arbor 1.362
Seattle 1.181
Wilmington 1.132
Cambridge 977
Ho Chi Minh City 720
New York 667
Izmir 649
Nanjing 593
Los Angeles 588
Tokyo 536
Dallas 533
Hanoi 519
Warsaw 487
Munich 482
Princeton 480
Lauterbourg 436
Helsinki 408
Council Bluffs 358
San Diego 314
Ferrara 310
Boardman 309
Milan 285
São Paulo 267
Shanghai 224
Mexico City 220
Jakarta 206
Shenyang 190
Nanchang 172
Turku 171
Buffalo 168
Orem 146
London 142
Chicago 134
Dong Ket 132
Hebei 128
Tianjin 120
Bremen 115
Hefei 115
Addison 113
Haiphong 111
Da Nang 110
Montreal 110
Toronto 102
Changsha 101
Rome 99
Chennai 98
Johannesburg 91
Moscow 91
Rio de Janeiro 91
Brussels 90
Brooklyn 88
Falls Church 88
Jiaxing 88
Dearborn 83
Frankfurt am Main 82
Denver 80
Phoenix 79
Jinan 74
Zhengzhou 72
Stockholm 71
Atlanta 69
Mountain View 69
San Francisco 69
Bologna 65
Tashkent 65
Redwood City 63
Biên Hòa 62
Brasília 59
Falkenstein 59
Baghdad 58
Manchester 57
Poplar 57
Guangzhou 56
Norwalk 55
Nuremberg 54
Belo Horizonte 52
The Dalles 52
Brno 51
Lappeenranta 51
Amsterdam 50
Curitiba 50
Hải Dương 48
Kunming 46
Mumbai 46
San Mateo 46
Boston 45
Quito 45
Dhaka 40
Ningbo 40
Totale 46.663
Salva come PNG Salva come JPEG
Nome #
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 411
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 315
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 295
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 290
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 289
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 287
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 279
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 276
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 275
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 275
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 274
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 272
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 272
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 270
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 270
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia 269
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 268
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 266
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 266
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 265
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 264
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma 264
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 263
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 263
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 262
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 260
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 254
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 254
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 254
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 250
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 249
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 249
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 248
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 248
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 245
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 243
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 241
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 240
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. 239
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 239
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 237
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 235
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 232
Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings 231
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 230
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 229
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 229
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 229
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 228
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 228
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 227
Delirium in acute promyelocytic leukemia patients: Two case reports 226
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 225
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 224
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 224
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies 223
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 223
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 221
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 220
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 220
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. 219
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 219
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 218
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 218
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 217
Myelofibrosis with Myeloid Metaplasia (MMM)/Idiopathic myelofibrosis/Agnogenic myeloid metaplasia 216
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 214
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 214
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 212
Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation 212
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 212
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 211
Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome 210
A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia 209
Differentiation of follicular dendritic sarcoma cells into functional myeloiddendritic cell-like elements 208
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 208
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement 208
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 207
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 207
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 206
[Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature]. 206
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 206
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 205
Waldenstrom macroglobulinemia 205
MORFOLOGIA E FISIOPATOLOGIA DEL SANGUE E DEGLI ORGANI EMOPOIETICI 204
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 201
Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia 201
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 201
Dendritic cells in acute promyelocytic leukaemia 200
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 200
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 199
Early CP CML, Nilotinib 400 mg Twice Daily Frontline: Beyond 3 Years, Results Remain Excellent and Stable (A GIMEMA CML Working Party Trial) 198
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 198
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia 196
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 196
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile 194
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 194
Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome 193
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA 192
A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia 192
Totale 23.480
Salva come PNG Salva come JPEG
Categoria #
all - tutte 323.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 39.502
Totale 362.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021464 0 0 0 0 0 0 0 0 0 0 0 464
2021/20224.235 230 531 203 195 226 230 230 260 138 359 427 1.206
2022/20234.073 500 178 138 464 698 594 181 363 560 21 250 126
2023/20242.042 186 284 97 50 128 283 89 111 65 55 79 615
2024/20259.403 315 200 787 324 1.145 746 242 510 1.537 1.225 1.265 1.107
2025/202628.091 2.382 1.385 2.438 3.786 3.813 1.830 2.994 1.538 2.802 3.242 1.652 229
Totale 71.277